NasdaqCM - Delayed Quote USD

Motus GI Holdings, Inc. (MOTS)

0.1735 0.0000 (0.00%)
At close: April 15 at 4:00 PM EDT
Loading Chart for MOTS
DELL
  • Previous Close 0.1735
  • Open 0.0700
  • Bid --
  • Ask --
  • Day's Range 0.1735 - 0.1735
  • 52 Week Range 0.0670 - 23.4000
  • Volume 1,179,891
  • Avg. Volume 1,671,355
  • Market Cap (intraday) 904,087
  • Beta (5Y Monthly) 1.29
  • PE Ratio (TTM) --
  • EPS (TTM) -15.8900
  • Earnings Date May 8, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.30

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

www.motusgi.com

15

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: MOTS

Performance Overview: MOTS

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MOTS
86.39%
S&P 500
4.14%

1-Year Return

MOTS
98.73%
S&P 500
19.55%

3-Year Return

MOTS
99.94%
S&P 500
18.68%

5-Year Return

MOTS
99.98%
S&P 500
70.99%

Compare To: MOTS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MOTS

Valuation Measures

As of 4/18/2024
  • Market Cap

    364.76k

  • Enterprise Value

    -2.13M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.18

  • Price/Book (mrq)

    0.14

  • Enterprise Value/Revenue

    -6.66

  • Enterprise Value/EBITDA

    0.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -59.85%

  • Return on Equity (ttm)

    -454.34%

  • Revenue (ttm)

    319k

  • Net Income Avi to Common (ttm)

    -12.87M

  • Diluted EPS (ttm)

    -15.8900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.96M

  • Total Debt/Equity (mrq)

    91.85%

  • Levered Free Cash Flow (ttm)

    -6.05M

Research Analysis: MOTS

Analyst Price Targets

8.30
8.30 Average
0.1735 Current
8.30 High
 

Fair Value

Overvalued
% Return
0.1735 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch